Intact Toll-like receptor 9 signaling in neutrophils modulates normal thrombogenesis in mice
Background Deletion of Toll-like receptor 9 (Tlr9) signaling, which is important for sterile inflammatory processes, results in impaired resolution of venous thrombosis (VT) in mice. The purpose of this study was to determine if deletion of Tlr9 affected sterile necrosis, apoptosis, and neutrophil e...
Gespeichert in:
Veröffentlicht in: | Journal of vascular surgery 2016-11, Vol.64 (5), p.1450-1458.e1 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1458.e1 |
---|---|
container_issue | 5 |
container_start_page | 1450 |
container_title | Journal of vascular surgery |
container_volume | 64 |
creator | El-Sayed, Osama M., BS Dewyer, Nicholas A., MD Luke, Catherine E., LVT Elfline, Megan, MS Laser, Adriana, MD Hogaboam, Cory, PhD Kunkel, Steven L., PhD Henke, Peter K., MD |
description | Background Deletion of Toll-like receptor 9 (Tlr9) signaling, which is important for sterile inflammatory processes, results in impaired resolution of venous thrombosis (VT) in mice. The purpose of this study was to determine if deletion of Tlr9 affected sterile necrosis, apoptosis, and neutrophil extracellular trap (NET) production in VT. Methods Stasis and nonstasis murine models of VT were used in wild-type (WT) and Tlr9 −/− mice, with assessment of thrombus size and determination of NETs, necrosis, and apoptosis markers. Anti-polymorphonuclear neutrophil (PMN) and antiplatelet antibody strategies were used to determine the cellular roles and their roles in WT and Tlr9 −/− mice. Results At 2 days, stasis thrombi in Tlr9 −/− mice were 62% larger (n = 6-10), with 1.4-fold increased uric acid levels, 1.7-fold more apoptotic cells, 2-fold increased citrullinated histones, 2-fold increased peptidylarginine deiminase 4 (PAD4), and 1.5-fold increased elastase and a 2.4-fold reduction in tissue factor pathway inhibitor compared with WT mice (all n = 4-7; P < .05). In contrast, the sizes of nonstasis thrombi were not significantly different in Tlr9 −/− mice (n = 4-6), and they did not have elevated necrosis or NET markers. Stasis thrombus size was not reduced at the 2-day time point in WT or Tlr9 −/− mice that received treatment with deoxyribonuclease I or in PAD4 −/− mice, which are incapable of forming NETs. In Tlr9 −/− mice undergoing PMN depletion (n = 8-10), stasis thrombus size was reduced 18% and was associated with 29-fold decreased citrullinated histones, 1.3-fold decreased elastase, and 1.5-fold increased tissue factor pathway inhibitor (all n = 6; P < .05). Last, platelet depletion (>90% reduction) did not significantly reduce stasis thrombus size in Tlr9 −/− mice. Conclusions These data suggest that the thrombogenic model affects Tlr9 thrombogenic mechanisms and that functional Tlr9 signaling in PMNs, but not in platelets or NETs, is an important mechanism in early stasis experimental venous thrombogenesis. |
doi_str_mv | 10.1016/j.jvs.2015.08.070 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4834067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0741521415018182</els_id><sourcerecordid>1826638495</sourcerecordid><originalsourceid>FETCH-LOGICAL-c642t-9695a1c9d574793c9e0dafbf2466e6b52bbbe0f75b20b342b6ee3d5d161045383</originalsourceid><addsrcrecordid>eNp9kkFv1DAQhS0EokvhB3BBOXJJsB3bsYVUCVVAK1XiQLkhWY4z2fXWsRc7Wan_HkdbqsKBkw_z3hvPfIPQW4Ibgon4sG_2x9xQTHiDZYM7_AxtCFZdLSRWz9EGd4zUnBJ2hl7lvMeYEC67l-iMCiapUu0G_bwOs7FzdRu9r727gyqBhcMcU6Wq7LbBeBe2lQtVgGVO8bBzPldTHBZvZshViGkyvpp3KU593EKA7PIqn5yF1-jFaHyGNw_vOfrx5fPt5VV98-3r9eWnm9oKRudaCcUNsWrgHetUaxXgwYz9SJkQIHpO-74HPHa8p7hvGe0FQDvwgQiCGW9le44uTrmHpZ9gsBDmZLw-JDeZdK-jcfrvSnA7vY1HzWTLsOhKwPuHgBR_LZBnPblswXsTIC5ZE0mFaCVTvEjJSWpTzDnB-NiGYL1S0XtdqOiVisZSFyrF8-7p_x4dfzAUwceTAMqWjg6SztZBsDC4gmPWQ3T_jb_4x20LNGeNv4N7yPu4pIKxTKEz1Vh_X89ivQrCMZFltPY3Lva0rA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1826638495</pqid></control><display><type>article</type><title>Intact Toll-like receptor 9 signaling in neutrophils modulates normal thrombogenesis in mice</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>El-Sayed, Osama M., BS ; Dewyer, Nicholas A., MD ; Luke, Catherine E., LVT ; Elfline, Megan, MS ; Laser, Adriana, MD ; Hogaboam, Cory, PhD ; Kunkel, Steven L., PhD ; Henke, Peter K., MD</creator><creatorcontrib>El-Sayed, Osama M., BS ; Dewyer, Nicholas A., MD ; Luke, Catherine E., LVT ; Elfline, Megan, MS ; Laser, Adriana, MD ; Hogaboam, Cory, PhD ; Kunkel, Steven L., PhD ; Henke, Peter K., MD</creatorcontrib><description>Background Deletion of Toll-like receptor 9 (Tlr9) signaling, which is important for sterile inflammatory processes, results in impaired resolution of venous thrombosis (VT) in mice. The purpose of this study was to determine if deletion of Tlr9 affected sterile necrosis, apoptosis, and neutrophil extracellular trap (NET) production in VT. Methods Stasis and nonstasis murine models of VT were used in wild-type (WT) and Tlr9 −/− mice, with assessment of thrombus size and determination of NETs, necrosis, and apoptosis markers. Anti-polymorphonuclear neutrophil (PMN) and antiplatelet antibody strategies were used to determine the cellular roles and their roles in WT and Tlr9 −/− mice. Results At 2 days, stasis thrombi in Tlr9 −/− mice were 62% larger (n = 6-10), with 1.4-fold increased uric acid levels, 1.7-fold more apoptotic cells, 2-fold increased citrullinated histones, 2-fold increased peptidylarginine deiminase 4 (PAD4), and 1.5-fold increased elastase and a 2.4-fold reduction in tissue factor pathway inhibitor compared with WT mice (all n = 4-7; P < .05). In contrast, the sizes of nonstasis thrombi were not significantly different in Tlr9 −/− mice (n = 4-6), and they did not have elevated necrosis or NET markers. Stasis thrombus size was not reduced at the 2-day time point in WT or Tlr9 −/− mice that received treatment with deoxyribonuclease I or in PAD4 −/− mice, which are incapable of forming NETs. In Tlr9 −/− mice undergoing PMN depletion (n = 8-10), stasis thrombus size was reduced 18% and was associated with 29-fold decreased citrullinated histones, 1.3-fold decreased elastase, and 1.5-fold increased tissue factor pathway inhibitor (all n = 6; P < .05). Last, platelet depletion (>90% reduction) did not significantly reduce stasis thrombus size in Tlr9 −/− mice. Conclusions These data suggest that the thrombogenic model affects Tlr9 thrombogenic mechanisms and that functional Tlr9 signaling in PMNs, but not in platelets or NETs, is an important mechanism in early stasis experimental venous thrombogenesis.</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/j.jvs.2015.08.070</identifier><identifier>PMID: 26482993</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Apoptosis ; Biomarkers - blood ; Blood Coagulation - drug effects ; Deoxyribonuclease I - pharmacology ; Disease Models, Animal ; Extracellular Traps - metabolism ; Genotype ; Hydrolases - deficiency ; Hydrolases - genetics ; Male ; Mice, Inbred BALB C ; Mice, Knockout ; Necrosis ; Neutrophils - drug effects ; Neutrophils - metabolism ; Neutrophils - pathology ; Phenotype ; Signal Transduction ; Surgery ; Time Factors ; Toll-Like Receptor 9 - deficiency ; Toll-Like Receptor 9 - genetics ; Toll-Like Receptor 9 - metabolism ; Venous Thrombosis - blood ; Venous Thrombosis - genetics ; Venous Thrombosis - metabolism ; Venous Thrombosis - pathology</subject><ispartof>Journal of vascular surgery, 2016-11, Vol.64 (5), p.1450-1458.e1</ispartof><rights>Society for Vascular Surgery</rights><rights>2015 Society for Vascular Surgery</rights><rights>Copyright © 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c642t-9695a1c9d574793c9e0dafbf2466e6b52bbbe0f75b20b342b6ee3d5d161045383</citedby><cites>FETCH-LOGICAL-c642t-9695a1c9d574793c9e0dafbf2466e6b52bbbe0f75b20b342b6ee3d5d161045383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0741521415018182$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26482993$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>El-Sayed, Osama M., BS</creatorcontrib><creatorcontrib>Dewyer, Nicholas A., MD</creatorcontrib><creatorcontrib>Luke, Catherine E., LVT</creatorcontrib><creatorcontrib>Elfline, Megan, MS</creatorcontrib><creatorcontrib>Laser, Adriana, MD</creatorcontrib><creatorcontrib>Hogaboam, Cory, PhD</creatorcontrib><creatorcontrib>Kunkel, Steven L., PhD</creatorcontrib><creatorcontrib>Henke, Peter K., MD</creatorcontrib><title>Intact Toll-like receptor 9 signaling in neutrophils modulates normal thrombogenesis in mice</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>Background Deletion of Toll-like receptor 9 (Tlr9) signaling, which is important for sterile inflammatory processes, results in impaired resolution of venous thrombosis (VT) in mice. The purpose of this study was to determine if deletion of Tlr9 affected sterile necrosis, apoptosis, and neutrophil extracellular trap (NET) production in VT. Methods Stasis and nonstasis murine models of VT were used in wild-type (WT) and Tlr9 −/− mice, with assessment of thrombus size and determination of NETs, necrosis, and apoptosis markers. Anti-polymorphonuclear neutrophil (PMN) and antiplatelet antibody strategies were used to determine the cellular roles and their roles in WT and Tlr9 −/− mice. Results At 2 days, stasis thrombi in Tlr9 −/− mice were 62% larger (n = 6-10), with 1.4-fold increased uric acid levels, 1.7-fold more apoptotic cells, 2-fold increased citrullinated histones, 2-fold increased peptidylarginine deiminase 4 (PAD4), and 1.5-fold increased elastase and a 2.4-fold reduction in tissue factor pathway inhibitor compared with WT mice (all n = 4-7; P < .05). In contrast, the sizes of nonstasis thrombi were not significantly different in Tlr9 −/− mice (n = 4-6), and they did not have elevated necrosis or NET markers. Stasis thrombus size was not reduced at the 2-day time point in WT or Tlr9 −/− mice that received treatment with deoxyribonuclease I or in PAD4 −/− mice, which are incapable of forming NETs. In Tlr9 −/− mice undergoing PMN depletion (n = 8-10), stasis thrombus size was reduced 18% and was associated with 29-fold decreased citrullinated histones, 1.3-fold decreased elastase, and 1.5-fold increased tissue factor pathway inhibitor (all n = 6; P < .05). Last, platelet depletion (>90% reduction) did not significantly reduce stasis thrombus size in Tlr9 −/− mice. Conclusions These data suggest that the thrombogenic model affects Tlr9 thrombogenic mechanisms and that functional Tlr9 signaling in PMNs, but not in platelets or NETs, is an important mechanism in early stasis experimental venous thrombogenesis.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Biomarkers - blood</subject><subject>Blood Coagulation - drug effects</subject><subject>Deoxyribonuclease I - pharmacology</subject><subject>Disease Models, Animal</subject><subject>Extracellular Traps - metabolism</subject><subject>Genotype</subject><subject>Hydrolases - deficiency</subject><subject>Hydrolases - genetics</subject><subject>Male</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Knockout</subject><subject>Necrosis</subject><subject>Neutrophils - drug effects</subject><subject>Neutrophils - metabolism</subject><subject>Neutrophils - pathology</subject><subject>Phenotype</subject><subject>Signal Transduction</subject><subject>Surgery</subject><subject>Time Factors</subject><subject>Toll-Like Receptor 9 - deficiency</subject><subject>Toll-Like Receptor 9 - genetics</subject><subject>Toll-Like Receptor 9 - metabolism</subject><subject>Venous Thrombosis - blood</subject><subject>Venous Thrombosis - genetics</subject><subject>Venous Thrombosis - metabolism</subject><subject>Venous Thrombosis - pathology</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kkFv1DAQhS0EokvhB3BBOXJJsB3bsYVUCVVAK1XiQLkhWY4z2fXWsRc7Wan_HkdbqsKBkw_z3hvPfIPQW4Ibgon4sG_2x9xQTHiDZYM7_AxtCFZdLSRWz9EGd4zUnBJ2hl7lvMeYEC67l-iMCiapUu0G_bwOs7FzdRu9r727gyqBhcMcU6Wq7LbBeBe2lQtVgGVO8bBzPldTHBZvZshViGkyvpp3KU593EKA7PIqn5yF1-jFaHyGNw_vOfrx5fPt5VV98-3r9eWnm9oKRudaCcUNsWrgHetUaxXgwYz9SJkQIHpO-74HPHa8p7hvGe0FQDvwgQiCGW9le44uTrmHpZ9gsBDmZLw-JDeZdK-jcfrvSnA7vY1HzWTLsOhKwPuHgBR_LZBnPblswXsTIC5ZE0mFaCVTvEjJSWpTzDnB-NiGYL1S0XtdqOiVisZSFyrF8-7p_x4dfzAUwceTAMqWjg6SztZBsDC4gmPWQ3T_jb_4x20LNGeNv4N7yPu4pIKxTKEz1Vh_X89ivQrCMZFltPY3Lva0rA</recordid><startdate>20161101</startdate><enddate>20161101</enddate><creator>El-Sayed, Osama M., BS</creator><creator>Dewyer, Nicholas A., MD</creator><creator>Luke, Catherine E., LVT</creator><creator>Elfline, Megan, MS</creator><creator>Laser, Adriana, MD</creator><creator>Hogaboam, Cory, PhD</creator><creator>Kunkel, Steven L., PhD</creator><creator>Henke, Peter K., MD</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20161101</creationdate><title>Intact Toll-like receptor 9 signaling in neutrophils modulates normal thrombogenesis in mice</title><author>El-Sayed, Osama M., BS ; Dewyer, Nicholas A., MD ; Luke, Catherine E., LVT ; Elfline, Megan, MS ; Laser, Adriana, MD ; Hogaboam, Cory, PhD ; Kunkel, Steven L., PhD ; Henke, Peter K., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c642t-9695a1c9d574793c9e0dafbf2466e6b52bbbe0f75b20b342b6ee3d5d161045383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Biomarkers - blood</topic><topic>Blood Coagulation - drug effects</topic><topic>Deoxyribonuclease I - pharmacology</topic><topic>Disease Models, Animal</topic><topic>Extracellular Traps - metabolism</topic><topic>Genotype</topic><topic>Hydrolases - deficiency</topic><topic>Hydrolases - genetics</topic><topic>Male</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Knockout</topic><topic>Necrosis</topic><topic>Neutrophils - drug effects</topic><topic>Neutrophils - metabolism</topic><topic>Neutrophils - pathology</topic><topic>Phenotype</topic><topic>Signal Transduction</topic><topic>Surgery</topic><topic>Time Factors</topic><topic>Toll-Like Receptor 9 - deficiency</topic><topic>Toll-Like Receptor 9 - genetics</topic><topic>Toll-Like Receptor 9 - metabolism</topic><topic>Venous Thrombosis - blood</topic><topic>Venous Thrombosis - genetics</topic><topic>Venous Thrombosis - metabolism</topic><topic>Venous Thrombosis - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>El-Sayed, Osama M., BS</creatorcontrib><creatorcontrib>Dewyer, Nicholas A., MD</creatorcontrib><creatorcontrib>Luke, Catherine E., LVT</creatorcontrib><creatorcontrib>Elfline, Megan, MS</creatorcontrib><creatorcontrib>Laser, Adriana, MD</creatorcontrib><creatorcontrib>Hogaboam, Cory, PhD</creatorcontrib><creatorcontrib>Kunkel, Steven L., PhD</creatorcontrib><creatorcontrib>Henke, Peter K., MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>El-Sayed, Osama M., BS</au><au>Dewyer, Nicholas A., MD</au><au>Luke, Catherine E., LVT</au><au>Elfline, Megan, MS</au><au>Laser, Adriana, MD</au><au>Hogaboam, Cory, PhD</au><au>Kunkel, Steven L., PhD</au><au>Henke, Peter K., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intact Toll-like receptor 9 signaling in neutrophils modulates normal thrombogenesis in mice</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>2016-11-01</date><risdate>2016</risdate><volume>64</volume><issue>5</issue><spage>1450</spage><epage>1458.e1</epage><pages>1450-1458.e1</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><abstract>Background Deletion of Toll-like receptor 9 (Tlr9) signaling, which is important for sterile inflammatory processes, results in impaired resolution of venous thrombosis (VT) in mice. The purpose of this study was to determine if deletion of Tlr9 affected sterile necrosis, apoptosis, and neutrophil extracellular trap (NET) production in VT. Methods Stasis and nonstasis murine models of VT were used in wild-type (WT) and Tlr9 −/− mice, with assessment of thrombus size and determination of NETs, necrosis, and apoptosis markers. Anti-polymorphonuclear neutrophil (PMN) and antiplatelet antibody strategies were used to determine the cellular roles and their roles in WT and Tlr9 −/− mice. Results At 2 days, stasis thrombi in Tlr9 −/− mice were 62% larger (n = 6-10), with 1.4-fold increased uric acid levels, 1.7-fold more apoptotic cells, 2-fold increased citrullinated histones, 2-fold increased peptidylarginine deiminase 4 (PAD4), and 1.5-fold increased elastase and a 2.4-fold reduction in tissue factor pathway inhibitor compared with WT mice (all n = 4-7; P < .05). In contrast, the sizes of nonstasis thrombi were not significantly different in Tlr9 −/− mice (n = 4-6), and they did not have elevated necrosis or NET markers. Stasis thrombus size was not reduced at the 2-day time point in WT or Tlr9 −/− mice that received treatment with deoxyribonuclease I or in PAD4 −/− mice, which are incapable of forming NETs. In Tlr9 −/− mice undergoing PMN depletion (n = 8-10), stasis thrombus size was reduced 18% and was associated with 29-fold decreased citrullinated histones, 1.3-fold decreased elastase, and 1.5-fold increased tissue factor pathway inhibitor (all n = 6; P < .05). Last, platelet depletion (>90% reduction) did not significantly reduce stasis thrombus size in Tlr9 −/− mice. Conclusions These data suggest that the thrombogenic model affects Tlr9 thrombogenic mechanisms and that functional Tlr9 signaling in PMNs, but not in platelets or NETs, is an important mechanism in early stasis experimental venous thrombogenesis.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26482993</pmid><doi>10.1016/j.jvs.2015.08.070</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0741-5214 |
ispartof | Journal of vascular surgery, 2016-11, Vol.64 (5), p.1450-1458.e1 |
issn | 0741-5214 1097-6809 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4834067 |
source | MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Animals Apoptosis Biomarkers - blood Blood Coagulation - drug effects Deoxyribonuclease I - pharmacology Disease Models, Animal Extracellular Traps - metabolism Genotype Hydrolases - deficiency Hydrolases - genetics Male Mice, Inbred BALB C Mice, Knockout Necrosis Neutrophils - drug effects Neutrophils - metabolism Neutrophils - pathology Phenotype Signal Transduction Surgery Time Factors Toll-Like Receptor 9 - deficiency Toll-Like Receptor 9 - genetics Toll-Like Receptor 9 - metabolism Venous Thrombosis - blood Venous Thrombosis - genetics Venous Thrombosis - metabolism Venous Thrombosis - pathology |
title | Intact Toll-like receptor 9 signaling in neutrophils modulates normal thrombogenesis in mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T03%3A37%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intact%20Toll-like%20receptor%209%20signaling%20in%20neutrophils%20modulates%20normal%20thrombogenesis%20in%20mice&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=El-Sayed,%20Osama%20M.,%20BS&rft.date=2016-11-01&rft.volume=64&rft.issue=5&rft.spage=1450&rft.epage=1458.e1&rft.pages=1450-1458.e1&rft.issn=0741-5214&rft.eissn=1097-6809&rft_id=info:doi/10.1016/j.jvs.2015.08.070&rft_dat=%3Cproquest_pubme%3E1826638495%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1826638495&rft_id=info:pmid/26482993&rft_els_id=S0741521415018182&rfr_iscdi=true |